Yaoshibang, a Guangzhou-based business-to-business (B2B) pharmaceutical trading platform, announced that it has completed a US$133 million new round of financing from Tiger Global Management, DCM Ventures and China’s H Capital.
Tiger Global Management Co-Invests $133M In China’s B2B Pharma Trading Firm Yaoshibang
